Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Oxytocin Effects on Bone in Children With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating oxytocin for bone health in children with autism spectrum disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Elizabeth Austen Lawson | Conditions: Autism Spectrum Disorder, Bone Health | Phase 2 | Status: RECRUITING